Showing results (51-60 of 76) with videos related to
Sort By:
Pageof 8
Alimentary Pharmacology & Therapeutics|April 10, 2008
Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alpha-2a plus ribavirinV G Bain, S S Lee, K Peltekian, et al.Alimentary Pharmacology & Therapeutics|January 21, 2006
Treating chronic hepatitis C with pegylated interferon alfa-2a (40 KD) and ribavirin in clinical practiceS S Lee, V G Bain, K Peltekian, et al.Clinical and Diagnostic Virology|February 1, 1995
Multi-organ donor transmission of hepatitis C virus to five solid organ transplant recipients and lack of transmission to corneal transplant recipientsM Krajden, F Bishai, C Quan, et al.Journal of Viral Hepatitis|August 20, 2005
Clinical utility of viral load measurements in individuals with chronic hepatitis C infection on antiviral therapyN A Terrault, J-M Pawlotsky, J McHutchison, et al.Journal of Viral Hepatitis|November 26, 2016
Role of primary T-cell immunodeficiency and hepatitis B coinfection on spontaneous clearance of hepatitis C: The BC Hepatitis Testers CohortN Islam, M Krajden, M Gilbert, et al.Gut|May 20, 2006
Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapyM Sherman, E M Yoshida, M Deschenes, et al.Vaccine|January 1, 2013
Population-based evaluation of type-specific HPV prevalence among women in British Columbia, CanadaG S Ogilvie, D A Cook, D L Taylor, et al.Journal of the American Society of Nephrology : JASN|September 4, 1998
Clinical practice guidelines: prevention of cytomegalovirus disease after renal transplantationS V Jassal, J M Roscoe, J S Zaltzman, et al.Vaccine|July 9, 2024
Maternal-infant transfer of SARS-CoV-2 antibodies following vaccination in pregnancy: A prospective cohort studyI Korchinski, C Marquez, E McClymont, et al.Journal of Viral Hepatitis|December 20, 2007
Exploring differences in response to treatment with peginterferon alpha 2a (40kD) and ribavirin in chronic hepatitis C between genotypes 2 and 3J Powis, K M Peltekian, S S Lee, et al.Pageof 8